Han Ziying, Madara Jonathan J, Herbert Andrew, Prugar Laura I, Ruthel Gordon, Lu Jianhong, Liu Yuliang, Liu Wenbo, Liu Xiaohong, Wrobel Jay E, Reitz Allen B, Dye John M, Harty Ronald N, Freedman Bruce D
Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America.
PLoS Pathog. 2015 Oct 29;11(10):e1005220. doi: 10.1371/journal.ppat.1005220. eCollection 2015 Oct.
Hemorrhagic fever viruses, including the filoviruses (Ebola and Marburg) and arenaviruses (Lassa and Junín viruses), are serious human pathogens for which there are currently no FDA approved therapeutics or vaccines. Importantly, transmission of these viruses, and specifically late steps of budding, critically depend upon host cell machinery. Consequently, strategies which target these mechanisms represent potential targets for broad spectrum host oriented therapeutics. An important cellular signal implicated previously in EBOV budding is calcium. Indeed, host cell calcium signals are increasingly being recognized to play a role in steps of entry, replication, and transmission for a range of viruses, but if and how filoviruses and arenaviruses mobilize calcium and the precise stage of virus transmission regulated by calcium have not been defined. Here we demonstrate that expression of matrix proteins from both filoviruses and arenaviruses triggers an increase in host cytoplasmic Ca2+ concentration by a mechanism that requires host Orai1 channels. Furthermore, we demonstrate that Orai1 regulates both VLP and infectious filovirus and arenavirus production and spread. Notably, suppression of the protein that triggers Orai activation (Stromal Interaction Molecule 1, STIM1) and genetic inactivation or pharmacological blockade of Orai1 channels inhibits VLP and infectious virus egress. These findings are highly significant as they expand our understanding of host mechanisms that may broadly control enveloped RNA virus budding, and they establish Orai and STIM1 as novel targets for broad-spectrum host-oriented therapeutics to combat these emerging BSL-4 pathogens and potentially other enveloped RNA viruses that bud via similar mechanisms.
出血热病毒,包括丝状病毒(埃博拉病毒和马尔堡病毒)和沙粒病毒(拉沙病毒和胡宁病毒),是严重的人类病原体,目前尚无美国食品药品监督管理局(FDA)批准的治疗方法或疫苗。重要的是,这些病毒的传播,特别是出芽的后期步骤,严重依赖于宿主细胞机制。因此,针对这些机制的策略代表了面向宿主的广谱治疗的潜在靶点。先前在埃博拉病毒出芽过程中涉及的一个重要细胞信号是钙。事实上,宿主细胞钙信号在一系列病毒的进入、复制和传播步骤中所起的作用越来越受到认可,但丝状病毒和沙粒病毒是否以及如何动员钙以及钙调节病毒传播的确切阶段尚未明确。在这里,我们证明丝状病毒和沙粒病毒的基质蛋白表达通过一种需要宿主Orai1通道的机制触发宿主细胞质Ca2+浓度的增加。此外,我们证明Orai1调节病毒样颗粒(VLP)以及传染性丝状病毒和沙粒病毒的产生和传播。值得注意的是,抑制触发Orai激活的蛋白(基质相互作用分子1,STIM1)以及Orai1通道的基因失活或药理阻断会抑制VLP和传染性病毒的释放。这些发现具有高度重要性,因为它们扩展了我们对可能广泛控制包膜RNA病毒出芽的宿主机制 的理解,并且它们将Orai和STIM1确立为面向宿主的广谱治疗的新靶点,以对抗这些新出现的生物安全4级(BSL - 4)病原体以及可能通过类似机制出芽的其他包膜RNA病毒。